ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,490Medicare Part D Prescriptions Filled, Including Refills

Rank: 109 out of 1942

$497K Total Retail Price of All Prescriptions

Rank: 101 out of 1942

507 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
47% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Minnesota
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 507 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 507 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 8,477 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 20%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Minnesota
SIMVASTATIN 587 542 1 1
FUROSEMIDE 335 316 2 5
OMEPRAZOLE 327 283 3 4
LISINOPRIL 310 282 4 2
LEVOTHYROXINE SODIUM 280 250 5 3
METOPROLOL SUCCINATE 230 215 6 13
METOPROLOL TARTRATE 210 193 7 9
WARFARIN SODIUM 182 182 8 11
AMLODIPINE BESYLATE 158 145 9 6
POTASSIUM CHLORIDE 154 140 10 17
LISINOPRIL-HYDROCHLOROTHIAZIDE 154 132 10 22
ATENOLOL 152 135 12 7
MIRTAZAPINE 145 144 13 38
HYDROCODONE-ACETAMINOPHEN 135 102 S3 14 12
ADVAIR DISKUS 126 115 15 35
DIGOXIN 121 119 16 40
ATORVASTATIN CALCIUM 121 101 16 14
PRAVASTATIN SODIUM 120 103 18 23
GABAPENTIN 116 113 19 16
JANTOVEN 115 101 20 33
FLUOXETINE HCL 113 111 21 45
CARVEDILOL 111 107 22 39
METFORMIN HCL 105 74 23 10
CITALOPRAM HBR 102 81 24 15
PREDNISONE 102 102 24 27
POLYETHYLENE GLYCOL 3350 98 87 26 28
DONEPEZIL HCL 93 93 27 30
TRIAMTERENE-HCTZ 88 87 28 36
ALENDRONATE SODIUM 88 79 28 21
LOVASTATIN 87 85 30 32
CYMBALTA 86 69 31 62
GLIMEPIRIDE 86 74 31 53
HYDROCHLOROTHIAZIDE 84 69 33 8
ISOSORBIDE MONONITRATE ER 80 80 34 42
LANTUS SOLOSTAR 78 69 35 54
LOSARTAN POTASSIUM 74 60 36 18
GLYBURIDE 71 48 R 37 69
ATENOLOL-CHLORTHALIDONE 71 67 37 115
CLOPIDOGREL 64 62 39 55
ALLOPURINOL 62 60 40 26
DOXAZOSIN MESYLATE 57 54 41 72
RANITIDINE HCL 57 32 41 31
DIOVAN 56 56 43 44
SERTRALINE HCL 55 46 44 20
TRIAMCINOLONE ACETONIDE 54 51 45 71
KLOR-CON M20 53 53 46 97
PANTOPRAZOLE SODIUM 53 43 46 48
TRAZODONE HCL 53 38 46 24
PLAVIX 51 49 49 83
PROPRANOLOL HCL 50 50 50 101
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 22, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.